Courtney M. Lappas, Ph.D. - Publications

Affiliations: 
2006 University of Virginia, Charlottesville, VA 
Area:
Pharmacology, Immunology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Lappas CM. The plant hormone zeatin riboside inhibits T lymphocyte activity via adenosine A2A receptor activation. Cellular & Molecular Immunology. 12: 107-12. PMID 24813229 DOI: 10.1038/cmi.2014.33  0.489
2011 Chehata VJ, Domeier PP, Weilnau JN, Lappas CM. Adenosine A(2A) receptor activation limits chronic granulomatous disease-induced hyperinflammation. Cellular Immunology. 267: 39-49. PMID 21130984 DOI: 10.1016/j.cellimm.2010.11.002  0.496
2010 Lappas CM, Liu PC, Linden J, Kang EM, Malech HL. Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Journal of Leukocyte Biology. 87: 345-54. PMID 19889728 DOI: 10.1189/Jlb.0609388  0.539
2008 Srinivasan S, Bolick DT, Lukashev D, Lappas C, Sitkovsky M, Lynch KR, Hedrick CC. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. Diabetes. 57: 484-93. PMID 18003758 DOI: 10.2337/Db07-0855  0.308
2006 Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. The Journal of Experimental Medicine. 203: 2639-48. PMID 17088433 DOI: 10.1084/Jem.20061097  0.5
2006 Naganuma M, Wiznerowicz EB, Lappas CM, Linden J, Worthington MT, Ernst PB. Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. Journal of Immunology (Baltimore, Md. : 1950). 177: 2765-9. PMID 16920910 DOI: 10.4049/Jimmunol.177.5.2765  0.584
2005 Lappas CM, Sullivan GW, Linden J. Adenosine A2A agonists in development for the treatment of inflammation. Expert Opinion On Investigational Drugs. 14: 797-806. PMID 16022569 DOI: 10.1517/13543784.14.7.797  0.547
2005 Lappas CM, Rieger JM, Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 1073-80. PMID 15634932 DOI: 10.4049/Jimmunol.174.2.1073  0.59
2004 Sullivan GW, Lee DD, Ross WG, DiVietro JA, Lappas CM, Lawrence MB, Linden J. Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils. Journal of Leukocyte Biology. 75: 127-34. PMID 14525968 DOI: 10.1189/Jlb.0603300  0.554
Show low-probability matches.